purpos
aim
present
work
develop
solid
lipid
microparticl
slm
dri
powder
contain
quercetin
direct
administr
lung
method
quercetin
microparticl
prepar
ow
emulsif
via
phase
invers
techniqu
use
tristearin
lipid
compon
pho
phatidylcholin
emulsifi
quercetin
slm
characteris
morpholog
drug
load
correspond
encapsul
effici
particl
size
distribut
respons
humid
crystallin
thermal
behaviour
vitro
respir
fraction
furthermor
toxic
vitro
transport
slm
air
liquid
interfac
model
cell
line
also
investig
use
modifi
twinstag
imping
apparatu
result
result
show
quercetin
slm
could
formul
dri
powder
suitabl
inhal
drug
deliveri
fine
particl
fraction
lm
absorb
via
linear
kinet
model
across
monolay
h
add
ition
que
rcetin
slm
shown
nontox
concentr
investig
interestingli
apic
basolater
transport
micronis
quercetin
observ
period
studi
conclus
observ
suggest
quercetin
diffus
enhanc
presenc
lipid
emulsifi
excipi
slm
howev
studi
necessari
elucid
exact
mechan
quercetin
flavonoid
natur
substanc
phenol
structur
flavonoid
divid
variou
class
basi
molecula
r
structur
quercetin
belong
flavon
class
planar
structur
due
doubl
bond
central
ring
backbon
flavonoid
group
found
abund
onion
appl
broccoli
berri
nijveldt
et
al
formica
regelson
quercetin
pharmacokin
tic
bioavail
human
previousl
studi
graef
et
al
import
effect
quercetin
abil
scaveng
oxygend
ive
free
radic
heijnen
et
al
given
antioxid
properti
low
concentr
robaszkiew
icz
et
al
furthermor
e
vitro
vivo
experi
also
shown
flavonoid
possess
potenti
antiinflammatori
antiallerg
antivir
anticarcinogeni
c
antiasthma
tic
properti
pettinari
et
al
wu
et
al
li
et
al
davi
et
al
gang
et
al
specif
lung
cell
cultur
studi
shown
quercetin
reduc
infect
target
cell
replic
wide
varieti
respiratori
virus
includ
herp
simplex
viru
adenoviru
chiang
et
al
coronaviru
debiaggi
et
al
parainfluenza
respiratori
syncyti
viru
kaul
et
al
rhinoviru
dimova
et
al
sever
acut
respirato
ry
syndrom
chen
et
al
furthermor
e
evid
quercetin
play
critic
role
amelior
pathogen
process
asthma
murin
model
mice
park
et
al
due
alter
specif
cytokin
product
transcriptor
factor
tbet
gene
express
ovainduc
asthma
model
mice
suggest
quercetin
could
use
new
therapeut
approach
allerg
airway
diseas
recent
given
oral
guinea
pig
quercetin
found
reduc
hyperreacti
viti
airway
one
main
attribut
allerg
asthma
joskova
et
al
caus
signific
broncodil
furthermor
report
suggest
flavonoid
quercetin
luteolin
could
stimul
cl
secret
activ
entri
step
cl
across
basolat
al
membran
na
k
cotranspor
ter
contribut
maintenanc
e
andor
product
airway
surfac
liquid
regulatin
g
cl
secret
airway
epitheli
cell
asano
et
al
import
chronic
obstructi
pulmonari
diseas
quercetin
sparingli
solubl
water
poor
bioavail
result
clinic
applicati
drug
greatli
restrict
previou
studi
tri
resolv
issu
produc
nanocryst
enhanc
dissolut
kakran
et
al
li
et
al
altern
approach
would
incorpor
drug
lipid
matrix
li
et
al
product
solid
lipid
micropart
le
slm
previous
studi
respiratori
drug
deliveri
vehicl
poorli
watersolubl
drug
budesonid
watersolub
le
drug
salbutamol
scalia
et
al
mani
advantag
use
slm
jaspart
et
al
signific
abil
control
releas
deposit
furthermor
slm
well
toler
vivo
sinc
made
physiolog
ical
compound
cours
toxic
surfact
excipi
use
manufactur
need
consid
solid
lipid
nanoparticl
es
current
attract
lot
attent
research
communi
ty
solid
lipid
micropatrt
le
rather
unexploit
especi
inhal
drug
deliveri
scalia
et
al
jaspart
et
al
particl
optimum
aerodynam
diamet
lm
patton
mezzena
et
al
scalia
et
al
use
concept
deliv
budesonid
salbutamol
two
antiasthma
drug
respect
use
glycerol
behen
solid
lipid
compon
studi
dellamari
et
al
use
dipalmitoyl
phosphatidylch
olin
biocompat
lipid
compon
normal
lung
surfact
modul
immunoglo
bulin
releas
sanna
et
al
appli
concept
formulat
ion
slm
use
carrier
lung
deliveri
use
compritol
lipophil
compon
poloxam
emulsifi
agent
aim
studi
investig
potenti
use
solid
lipid
micropart
le
contain
quercetin
deliv
dri
powder
inhal
physicochemi
cal
characterist
formul
investig
togeth
aerosol
performanc
e
vitro
cell
toxic
transport
studi
use
adenocarcinoma
cell
line
grown
use
airinterfac
model
micronis
quercetin
hydrat
refer
quercetin
hereaft
tristearin
suppli
sigma
aldrich
steinheim
germani
phosphatidylchol
ine
suppli
cargil
hamburg
germani
ammonium
acet
suppli
ajax
finechem
pti
ltd
sydney
australia
acet
acid
purchas
analar
vwr
intern
pool
england
edta
disodium
salt
suppli
ap
finechem
sydney
australia
cell
line
purchas
american
type
cell
cultur
collect
attc
rockvil
usa
dulbecco
modifi
eagl
medium
fetal
bovin
serum
hank
balanc
salt
solut
phosphat
buffer
salin
hepe
trypsinedta
solut
gl
trypsin
gl
edta
lglutamin
solut
mm
nonessenti
amino
acid
solut
cellyt
cell
lysi
mm
trishcl
ph
mm
nacl
sodium
deoxycholat
e
sd
suppli
invitrogen
sydney
australia
transwel
l
cell
cultur
support
cm
polyest
lm
pore
size
obtain
corn
costar
lowel
usa
solvent
analytica
l
grade
obtain
sigma
sydney
australia
water
purifi
milliq
revers
osmosi
molsheim
franc
develop
slm
load
quercetin
melt
ow
emulsif
techniqu
e
employ
sinc
circumv
use
organ
solvent
jaspart
et
al
approach
environmental
friendli
also
elimin
potenti
residu
solvent
final
dosag
form
quercetin
g
dissolv
melt
lipid
phase
g
tristearin
phase
invers
obtain
ad
hot
milliq
water
ml
contain
g
phosphat
idylcholin
surfact
mixtur
maintain
subject
highshear
mix
rpm
min
use
ultraturrax
ikaw
k
staufen
germani
addit
alli
ow
emuls
sonic
constant
duti
cycl
khz
min
use
probe
microson
ultrason
cell
disruptor
misonix
farmingd
ale
ny
power
input
w
emuls
quickli
cool
room
temperatur
use
ice
bath
form
micropart
le
recov
freezedri
hetosicc
heto
lab
equip
saintjuli
canada
amount
quercetin
entrap
slm
determin
heat
min
sonic
min
micropar
ticl
mg
ethanol
seal
glass
vial
obtain
sampl
dilut
volum
ml
methano
l
filter
assay
high
performanc
e
liquid
chromatograp
hy
hplc
physic
chemic
characterisati
particl
size
analysi
particl
size
distribut
slm
analys
use
laser
diffract
malvern
masters
malvern
instrument
ltd
uk
sampl
powder
ca
mg
dispers
use
scirocco
dri
dispers
unit
malvern
uk
feed
pressur
bar
feed
rate
sampl
analys
triplic
obscurati
valu
refer
refract
index
scan
electron
microscopi
morpholog
slm
particl
studi
use
field
emiss
scan
electron
microscop
zeiss
ultra
plu
carl
zeiss
pti
ltd
sydney
australia
sampl
sputter
coat
gold
thick
nm
argon
atmosph
ere
prior
analysi
sampl
dispers
onto
carbon
sticki
tab
imag
taken
random
locat
differenti
scan
calorimetri
thermal
respons
quercetin
raw
materi
slm
powder
studi
use
differenti
scan
calorimetri
dsc
mettlertol
edo
schwerzenbach
switzerland
sampl
mg
crimpseal
dsc
sampl
pan
expos
min
temperatur
ramp
exotherm
endothermi
c
peak
temperatur
onset
temperat
ure
heat
enthalpi
dh
peak
determin
use
stare
softwar
mettler
toledo
greifense
switzerla
nd
xray
powder
diffract
xray
powder
diffract
xrpd
pattern
slm
analys
use
xray
powder
diffractom
ter
siemen
munich
germani
measur
conduct
use
cu
ka
radiat
kv
angular
increment
dynam
vapour
sorption
dynam
vapour
sorption
dv
use
investiga
te
rel
moistur
sorption
stabil
quercetin
raw
materi
slm
respect
humid
sampl
ca
mg
ad
glass
sampl
pan
place
sampl
chamber
dv
surfac
measur
system
ltd
london
uk
sampl
dri
rh
expos
rh
increment
two
rh
cycl
equilibrium
moistur
content
humid
step
determin
dmdt
min
chemic
analysi
quercetin
perform
highperform
liquid
chromatograp
hy
hplc
use
shimadzu
promin
uflc
system
equip
uvvi
detector
solvent
deliveri
unit
ht
autosampl
shimadzu
corpor
japan
novapak
column
lm
mm
water
ireland
hplc
set
follow
detect
wavelength
nm
flow
rate
ml
min
inject
volum
retent
time
min
mobil
phase
mixtur
acet
buffer
acetonitril
vv
mm
edta
standard
linear
obtain
lg
ml
aerosolis
quercetin
slm
analys
use
aerol
dri
powder
inhal
dpi
devic
novarti
surrey
uk
next
gener
impactor
ngi
copley
scientif
nottingham
uk
accord
method
specifi
dri
powder
inhal
pharmacopoei
british
pharmacop
oeia
briefli
prior
test
eight
ngi
collect
cup
coat
silicon
oil
elimin
particl
bounc
mg
mg
quercetin
slm
weigh
fill
size
gelatin
capsul
capsugel
sydney
australia
place
aerol
mouthpiec
adaptor
fit
unit
state
pharmacopei
usp
throat
use
connect
aerol
ngi
particl
aerolis
l
min
devic
contain
capsul
throat
stage
wash
separ
methano
l
sampl
analys
use
hplc
mass
balanc
calcul
recoveri
stage
deposit
capsul
devic
addit
fine
particl
dose
fpd
drug
recov
stage
filter
lm
fine
particl
fraction
fpf
fpdtotal
dose
calcul
toxic
quercetin
slm
assess
measur
viabil
cell
liquid
cover
cultur
follow
day
drug
exposur
increas
drug
concentratio
ns
previousl
describ
haghi
et
al
briefli
cell
seed
per
well
volum
well
plate
cell
incub
overnight
co
atmospher
h
increas
addit
measurem
nt
transepith
lial
electr
resist
teer
perform
use
evom
voltohmm
eter
world
precis
instrument
usa
connect
chopstick
electrod
measur
ment
taken
per
well
experi
confirm
mainten
barrier
integr
h
experi
subtract
resist
cellfre
insert
correct
valu
surfac
area
transwel
calcul
resist
vitro
drug
diffusiontransp
ort
studi
use
air
interfac
cell
cultur
transport
quercetin
slm
studi
use
lung
epitheli
model
cultur
condit
cell
air
interfac
model
previous
describ
haghi
et
al
briefli
cell
grown
subcultur
ed
dulbecco
modifi
eagl
medium
contain
vv
fetal
calf
serum
vv
non
essenti
amino
acid
solut
vv
lglutamin
solut
cell
seed
transwel
l
polyest
insert
densiti
cell
cm
h
medium
remov
apic
chamber
basolat
al
medium
replac
everi
altern
day
fresh
medium
establish
airinterf
ace
model
day
prior
transport
studi
viabil
integr
cell
monolay
respect
quercetin
slm
evalu
modifi
vitro
aerosol
test
apparatu
twin
stage
imping
tsi
radley
essex
uk
allow
attach
transwel
contain
epitheli
cell
use
studi
mechani
drug
deposit
dissolut
diffusiontransp
ort
haghi
et
al
haghi
et
al
drug
transport
studi
tsi
flow
rate
set
l
min
use
rotari
vein
pump
calibr
flow
meter
quercetin
slm
sampl
weigh
mg
mg
size
gelatin
capsul
insert
aerol
devic
pump
activ
dispers
powder
tsi
disassembl
transwel
l
remov
deposit
powder
transwel
place
well
plate
contain
modifi
buffer
hbss
supplem
ent
hepe
vv
ethanol
v
v
ph
measur
quercetin
transport
min
time
point
transwel
move
new
well
contain
fresh
modifi
buffer
h
surfac
monolay
wash
transport
buffer
account
drug
remain
cell
surfac
cell
lyse
cell
lytic
solut
allow
measur
ment
drug
cell
lysat
centrifug
rpm
min
supernat
collect
dilut
appropri
volum
sampl
analys
hplc
initi
amount
deposit
cell
layer
calcul
sum
drug
pass
cell
monolay
er
mass
retain
monolay
er
end
experim
nt
mass
drug
insid
cell
experim
nt
randomis
dose
repeat
three
time
data
subject
statist
analysi
spss
use
anova
oneway
analysi
examin
signific
differenc
e
signific
differ
formul
analys
use
multipl
comparison
tukey
post
hoc
test
p
valu
consid
signific
prepar
slm
tristearin
hydrogen
phosphatidi
lcholin
select
respect
lipid
materi
surfact
base
previou
studi
developmen
quercetinlo
ade
lipid
micropart
le
dermal
applic
addit
phosphatidi
lcholin
physiolog
compat
emulsifi
phosphatidylcholin
major
compon
lung
endogen
surfact
quercetin
content
slm
wv
correspond
encapsul
effici
encapsul
effici
base
recov
amount
quercetin
microparticl
function
theoret
amount
present
powder
take
account
excipi
content
particl
size
distribut
ion
suppli
micronis
quercetin
quercetin
slm
shown
fig
analysi
data
indic
median
volum
diamet
lm
lm
respect
analysi
suggest
slm
diamet
lm
scan
electron
microscop
imag
slm
assuppli
quercetin
shown
fig
b
respectivel
gener
slm
particl
spheric
morpholog
size
line
particl
size
analysi
raw
quercetin
columnar
shape
larger
lm
import
note
particl
size
data
repres
volum
distribut
make
seri
assumpt
ie
uniform
sphere
sem
morpholog
techniqu
e
reflect
differ
observ
particl
size
compar
sem
imag
particl
appear
elong
platelik
morpholog
particl
size
distribut
slm
appropri
size
respiratori
deliveri
patton
similar
measur
use
laser
diffract
thermal
respons
slm
compon
tristearin
phosphatidylchol
ine
quercetin
well
prepar
slm
display
fig
tristearin
commerci
monoacid
triglycerid
gener
triglycerid
exhibit
three
differ
polymorph
form
characteris
particular
chain
pack
thermal
stabil
alpha
betaprim
b
beta
b
hernqvist
specif
experi
tristearin
present
endotherm
correspond
melt
b
phase
similar
previou
literatur
lutton
phosphati
dylcholin
surfaceact
molecul
transit
temperat
ure
crystallin
mesomo
rphic
liquid
crystallin
visibl
around
agreement
previous
report
valu
rutven
mcelhaney
dsc
thermogram
quercetin
raw
materi
exhibit
endothermi
c
peak
typic
melt
line
literatur
data
borghetti
et
al
anoth
smaller
endotherm
peak
visibl
around
relat
decompo
sition
process
water
loss
da
costa
et
al
dsc
thermogram
prepar
slm
show
notic
reduct
melt
point
compari
quercetin
raw
materi
follow
endothermi
c
respons
result
support
variou
previou
studi
conduct
phospholipid
complex
phytoconsti
tuent
silybin
puerarin
curcumin
naringenin
gallic
acid
maiti
et
al
semalti
et
al
hypoth
ise
main
exotherm
event
due
melt
primari
excipi
tristearin
simultan
dissolut
drug
phospholipid
melt
signific
dsc
data
quercetin
appear
incorpor
matrix
essenti
requiremen
respect
stabil
releas
profil
modif
diffractogra
raw
quercetin
quercetin
slm
measur
use
xrpd
shown
fig
xrpd
pattern
start
materi
indic
highli
crystallin
structur
evid
sharp
peak
observ
valu
good
agreement
previou
studi
quercetin
sri
et
al
comparison
slm
characterist
peak
crystallin
structur
suggest
particl
amorph
incorporati
drug
lipid
matrix
like
enhanc
stabil
drug
control
releas
deposit
reflect
dv
vitro
experi
present
section
respectiev
dri
powder
inhal
inherentl
suscept
moistur
sorption
thu
elev
rel
humid
rh
studi
slm
powder
expos
two
rh
cycl
use
dv
time
vs
mass
plot
function
humid
shown
fig
moistur
sorption
isotherm
first
humid
ramp
cycl
shown
fig
gener
formulat
ion
compon
revers
term
moistur
sorptiond
orption
suggest
irrevers
polymorph
chang
crystalis
phenomena
moistur
sorption
highest
phosphat
idylcholin
rh
compar
quercetin
tristearin
respect
moistur
sorption
slm
rh
reduct
moistur
sorption
slm
comparison
phosphatidi
lcholin
equat
slm
particl
mass
like
due
contribut
effect
drug
tristearin
make
major
particl
presenc
phosphatidylchol
ine
surfac
particl
contribut
high
humid
sorption
slm
aerosolis
performanc
e
quercetin
slm
studi
use
ngi
data
present
fig
analysi
stage
deposit
data
capsul
devic
recoveri
indic
load
dose
recov
across
stage
indic
good
mass
balanc
addit
fine
particl
dose
fpd
fine
particl
fraction
fpf
calcul
lg
fpd
fpf
repres
dose
percentag
drug
concentratio
ns
aerodynam
diamet
less
lm
suitabl
inhalatio
n
deliveri
dose
respons
cytotox
profil
quercetin
slm
cell
establish
shown
fig
cell
cultur
expos
rang
slm
concentratio
ns
minimum
nm
maximum
nm
h
treatment
period
cell
viabil
calcul
refer
untreat
cell
averag
absorb
normalis
viabil
viabil
assay
demonst
rate
cell
could
toler
wide
rang
quercetin
concentr
valu
could
determin
across
concentratio
n
rang
thu
slm
consid
nontox
cell
teer
monolay
measur
min
exposur
quercetin
quercetin
slm
tristearin
phosphat
idylcholin
perform
determin
compon
formul
could
chang
integr
epitheli
cell
found
signific
differ
p
control
cell
cell
treat
quercetin
x
cm
quercetin
slm
x
cm
tristearin
x
cm
phosphatidi
lcholin
x
cm
codepositio
n
tristearin
phosphatidylch
olin
x
cm
although
author
knowledg
previou
viabil
studi
use
epitheli
cell
flavonoid
ubiquit
human
diet
highli
bioavail
extens
ly
studi
regard
pharmacolog
toxicolog
rossand
kasum
furthermor
e
multipl
laboratori
clinic
trial
point
excel
safeti
profil
quercetin
includ
studi
use
system
oral
intraven
administrat
ion
hard
et
al
consequentl
studi
could
safe
assum
quercetin
slm
toxic
concentr
ation
studi
vitro
drug
diffusiontra
nsport
studi
use
air
interfac
cell
cultur
percentag
drug
transport
cell
grown
transwel
l
aic
configur
attach
modifi
tsi
apparatu
shown
fig
drug
concentr
ation
measur
express
term
percent
total
recoveri
througho
ut
experi
data
plot
mean
cumul
percentag
deviat
drug
transport
h
data
analysi
demonstrat
es
linear
kinet
profil
maximum
drug
transport
h
slm
formul
importan
tli
quercetin
detect
basal
chamber
h
deposit
micronis
quercetin
micro
particl
observ
suggest
ratelimit
step
uptak
quercetin
slm
link
solubl
presum
due
amorph
natur
quercetin
trap
within
solid
lipid
matrix
sinc
flux
independen
quercetin
concentr
remain
cell
monolay
deposit
slm
cell
grown
aic
model
concentratio
n
quercetin
transport
basal
fig
quercetin
slm
aerosol
deposit
next
gener
impact
repres
ngi
stage
cut
diamet
lm
respect
compartm
nt
set
time
point
measur
cumulati
mass
percentag
transport
calcul
fig
depict
percentag
drug
transport
remain
cell
trap
within
cell
singl
quercetin
quercetin
slm
min
quercetin
slm
quercetin
alon
still
found
cell
surfac
slm
formul
quercetin
alon
respect
found
trap
insid
cell
drug
slm
formul
transport
across
found
basal
compart
quercetin
raw
materi
transport
basal
compartm
nt
phosphatidylchol
ine
previous
shown
skin
penetr
enhanc
characterist
ic
studi
saija
et
al
specif
previou
studi
also
shown
didecanoyllalphap
hosphatidylchol
ine
enhanc
nasal
absorpt
insulin
vitro
rabbit
nasal
mucosa
model
facilit
paracellul
ar
passag
revers
open
tight
junction
carsten
et
al
studi
deposit
transport
quercetin
slm
microni
ed
quercetin
alon
quantiti
deposit
differ
slm
lg
micronis
materi
lg
sinc
attempt
achiev
equival
deposit
mass
powder
epithelia
ie
includ
lipid
compon
addit
higher
mass
micronis
sampl
addit
test
studi
micronis
materi
would
transport
quercetin
slm
produc
epitheli
transport
across
cell
line
although
internalizat
ion
quercetin
observ
micron
sampl
enhanc
effect
achiev
lipid
micropart
le
could
trace
effect
deliveri
quercetin
cell
due
increas
contact
surfac
encapsul
ate
substanc
cell
addit
sinc
lipid
microparticl
enabl
slow
releas
quercetin
cell
surfac
time
extent
decompo
sitionoxidativ
e
degrad
reduc
compar
free
drug
immedi
avail
lipid
carrier
incorpor
drug
demonstrat
ed
increas
absorpt
circul
bodi
versu
standalon
compound
maeda
nontox
enhanc
proven
success
vivo
studi
addit
mechani
ms
paracellular
enhanc
suggest
gizurarson
bechgaard
instanc
increas
cell
membran
permeabl
caus
enhanc
incorpor
lumin
cell
membran
suggest
muranishi
could
induc
drug
transcellular
absorpt
unclear
although
studi
indic
absorpt
quercetin
enhanc
presenc
phosphat
idylcholin
tristearin
real
mechan
still
unclear
possibl
phospholipid
may
incorpor
lumin
cell
membran
may
constitut
primari
step
mechan
phosphatidylcholin
affect
tight
junction
permeabl
furthermor
chang
lipid
environm
ent
cell
membran
may
affect
basic
transport
properti
epithelium
addit
studi
need
evalu
possibl
studi
investig
formul
aerosol
deliveri
lung
solid
lipid
quercetin
microparticl
potenti
activ
pharmaceuti
cal
ingredi
asthma
therapi
demonstrat
ed
slm
particl
technolog
use
deliv
natur
deriv
flavonoid
treatment
rang
respiratori
diseas
effect
absorpt
enhanc
nontox
excipi
increas
permeabilit
quercetin
also
highlight
ed
make
approach
signific
sinc
raw
microni
ed
quercetin
transport
across
epithelia
author
knowl
ge
previou
studi
investig
quercetin
transport
mechani
use
cell
epitheli
monolay
import
aspect
studi
sinc
lung
epithelia
first
barrier
deposit
airway
studi
necessari
elucid
exact
mechan
due
natur
physiologica
l
composit
quercetin
compon
final
slm
system
potenti
use
biocomp
atibl
deliveri
system
modul
releas
inhal
dri
powder
formulat
ion
